Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The anandamide membrane transporter (AMT), also known as the anandamide uptake transport system or endocannabinoid transporter (EMT), is a hypothesized membrane-associated transport system that facilitates the cellular reuptake of the endocannabinoid anandamide (N-arachidonoylethanolamine, AEA) from the extracellular space. This transport system plays a critical role in terminating endocannabinoid signaling by clearing AEA from synaptic and extracellular environments, delivering it intracellularly where it is subsequently degraded by fatty acid amide hydrolase (FAAH). Although its functional activity is well-characterized by saturable, temperature-dependent, and inhibitor-sensitive uptake, the exact molecular identity of a dedicated transmembrane AMT protein remains highly controversial and has not been cloned. Some evidence suggests that AEA uptake occurs via passive diffusion driven by an intracellular concentration gradient maintained by FAAH, or is facilitated by intracellular carriers such as fatty acid-binding proteins (FABPs) and FAAH-like anandamide transporter (FLAT). Despite the lack of a cloned molecular target, the AMT is considered a viable therapeutic target. Pharmacological inhibition of AMT using small molecules like AM404, VDM11, or UCM707 elevates extracellular anandamide levels, thereby enhancing cannabinoid receptor activation. This approach offers therapeutic potential for treating pain, inflammation, anxiety, and neurodegenerative diseases, potentially with fewer psychotropic side effects than direct cannabinoid receptor agonists.
Anandamide uptake inhibition
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anandamide membrane transporter (AMT).